Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86K Sell
308
-38
-11% -$9.99K 0.05% 447
2026
Q1
$92K Sell
346
-183
-35% -$49.6K 0.06% 329
2025
Q4
$133K Sell
529
-123
-19% -$32.7K 0.07% 400
2025
Q3
$187K Buy
652
+49
+8% +$13.1K 0.1% 243
2025
Q2
$158K Buy
603
+18
+3% +$4.38K 0.09% 292
2025
Q1
$136K Sell
585
-207
-26% -$50.2K 0.09% 306
2024
Q4
$182K Sell
792
-79
-9% -$18.1K 0.11% 215
2024
Q3
$195K Buy
+871
New +$191K 0.12% 182
2024
Q2
Sell
-805
Closed -$176K 2513
2024
Q1
$176K Sell
805
-35
-4% -$7.71K 0.11% 211
2023
Q4
$191K Buy
840
+338
+67% +$71K 0.13% 170
2023
Q3
$101K Buy
502
+24
+5% +$5.06K 0.08% 409
2023
Q2
$99K Sell
478
-5
-1% -$970 0.08% 447
2023
Q1
$95K Sell
483
-30
-6% -$6.17K 0.08% 401
2022
Q4
$104K Buy
513
+58
+13% +$11.3K 0.08% 366
2022
Q3
$80K Sell
455
-176
-28% -$36K 0.07% 473
2022
Q2
$127K Sell
631
-81
-11% -$17.3K 0.1% 281
2022
Q1
$162K Buy
712
+376
+112% +$88.4K 0.11% 238
2021
Q4
$91K Buy
+336
New +$83.2K 0.13% 208

Other funds holding LH

Covestor's LH Position: Q2 2026 in Review

Covestor reduced its Labcorp (LH) stake by 11% in Q2 2026, selling an estimated $9.99K and leaving 308 shares worth $86K. The position accounts for 0.05% of the portfolio, ranked #447.

Covestor first reported a position in LH in Q4 2021 and has held it in 18 quarters since. The position peaked at $195K in Q3 2024. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Covestor held 308 shares of Labcorp worth $86K as of Q2 2026.
  • Covestor sold 38 Labcorp shares in Q2 2026, an estimated $9.99K.
  • Labcorp made up 0.05% of Covestor's portfolio in Q2 2026, its #447 holding.
  • Covestor first reported a position in Labcorp in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Labcorp position peaked at $195K in Q3 2024.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.